HC Surgical Specialists (SGX:1B1) ROCE %: 25.75% (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGX:1B1 HC Surgical Specialists Ltd SGX:1B1
63 GF Score
Price S$0.34
GF Value S$0.30
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is HC Surgical Specialists ROCE %?

HC Surgical Specialists SGX:1B1 +1.45% 63 ROCE % is 25.75% as of May. 2026. GuruFocus rates SGX:1B1 with a GF Score™ of 63/100 and a GF Value™ of S$0.30 (Modestly Overvalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. HC Surgical Specialists's annualized ROCE % for the quarter that ended in May. 2026 was 25.75%.

HC Surgical Specialists  (SGX:1B1) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

HC Surgical Specialists ROCE % Related Terms

HC Surgical Specialists ROCE % Historical Data

* Premium members only.

The historical data trend for HC Surgical Specialists's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HC Surgical Specialists ROCE % Chart

HC Surgical Specialists Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.53 19.56 28.12 45.60 32.02

HC Surgical Specialists Semi-Annual Data
Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25 May26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.79 42.89 47.66 38.85 25.75
SGX:1B1
63GF Score
HC Surgical Specialists Ltd SGX:1B1
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HC Surgical Specialists ROCE % Calculation

HC Surgical Specialists's annualized ROCE % for the fiscal year that ended in May. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: May. 2026 )  (A: May. 2025 )(A: May. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: May. 2026 )  (A: May. 2025 )(A: May. 2026 )
=7.747/( ( (27.271 - 4.849) + (32.558 - 6.599) )/ 2 )
=7.747/( (22.422+25.959)/ 2 )
=7.747/24.1905
=32.02 %

HC Surgical Specialists's ROCE % of for the quarter that ended in May. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: May. 2026 )  (Q: Nov. 2025 )(Q: May. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: May. 2026 )  (Q: Nov. 2025 )(Q: May. 2026 )
=6.45/( ( (28.928 - 4.786) + (32.558 - 6.599) )/ 2 )
=6.45/( ( 24.142 + 25.959 )/ 2 )
=6.45/25.0505
=25.75 %

(1) Note: The EBIT data used here is two times the semi-annual (May. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 25.75% mean?
HC Surgical Specialists (SGX:1B1) has a ROCE % of 25.75% as of May. 2026.
Is HC Surgical Specialists' ROCE % too high?
HC Surgical Specialists' current ROCE % is 25.75%. Overall, HC Surgical Specialists has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HC Surgical Specialists' ROCE % compare to TMO and DHR?
HC Surgical Specialists' ROCE % of 25.75% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Diagnostics & Research company?
A good ROCE % depends on the Medical Diagnostics & Research industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. HC Surgical Specialists's current ROCE % is 25.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HC Surgical Specialists stock overvalued right now?
Based on GuruFocus' analysis, HC Surgical Specialists (SGX:1B1) is currently considered Modestly Overvalued. The stock's GF Value™ is S$0.30, compared to a current price of S$0.34 — trading 13.3% above its estimated fair value. The current ROCE % is 25.75%. HC Surgical Specialists' overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For HC Surgical Specialists (SGX:1B1), the current ROCE % is 25.75% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HC Surgical Specialists (SGX:1B1) Overvalued in 2026?

Based on GuruFocus' analysis, HC Surgical Specialists stock appears to be overvalued. The current stock price of S$0.34 is trading 13.3% above its estimated GF Value™ of S$0.30. GuruFocus considers HC Surgical Specialists to be Modestly Overvalued.

Key valuation signals for SGX:1B1:

  • ROCE %: 25.75%
  • GF Value™: S$0.30 vs. price of S$0.34 (13.3% above fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the SGX:1B1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HC Surgical Specialists Business Description

Address 233 River Valley Road, No. B1-04/05 RV Point, Singapore, SGP, 238291
HC Surgical Specialists Ltd is a medical services group. The company is engaged in providing endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services. The operating segment of the company is the healthcare segment. Geographically, it operates only in Singapore. The company has its facilities center and clinics at various places in Singapore.
63GF Score

Get the complete analysis for SGX:1B1

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$0.34
Price
S$0.30
GF Value